Monitoring and assessing vaccine safety: a European perspective

被引：12

作者：

Lopalco, Pier Luigi ^{[1
]}

Johansen, Kari ^{[1
]}

Ciancio, Bruno ^{[1
]}

Gomes, Helena De Carvalho ^{[1
]}

Kramarz, Piotr ^{[1
]}

Giesecke, Johan ^{[1
]}

机构：

[1] European Ctr Dis Prevent & Control, Sci Advice Unit, SE-17183 Stockholm, Sweden

来源：

EXPERT REVIEW OF VACCINES | 2010年 / 9卷 / 04期

关键词：

adverse effects; European Union; immunization program; vaccination; vaccine safety; HEPATITIS-B VACCINATION; CAMPAIGN; AUTISM; RISK; MMR;

D O I：

10.1586/ERV.10.20

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The success of vaccination programs is an uncontroversial reality in Europe as well as worldwide. On the other hand, the perceived risk of adverse events in the general public is the most important threat for implementing successful vaccination programs in Europe. For this reason, monitoring and assessing vaccine safety is a priority for public health. Vaccine safety is assessed both before and after vaccine authorization. In postmarketing settings, different activities related to vaccine safety usually involve several different stakeholders. In 2005, a new EU agency, the European Centre for Disease Prevention and Control, was established with the aim to strengthen Europe's defences against infectious diseases. Implementing stable links between different stakeholders and defining clear roles in the EU is paramount in order to provide optimal and transparent information on adverse reactions following immunization, with the final goal of increasing compliance to safe and effective vaccination programs.

引用

页码：371 / 380

页数：10

共 23 条

[21]

World Health Organization, ADV EV FOLL IMM AEFI

[22] Understanding variation in measles-mumps-rubella immunization coverage-a population-based study [J].

Wright, JA ;

Polack, C .

EUROPEAN JOURNAL OF PUBLIC HEALTH, 2006, 16 (02) :137-142

[23] Vaccine adverse event monitoring systems across the European Union countries: Time for unifying efforts [J].

Zanonia, Giovanna ;

Berra, Piero ;

Lucchi, Ilaria ;

Ferro, Antonio ;

O'Flanagan, Darina ;

Levy-Bruhl, Daniel ;

Salmaso, Stefania ;

Tridente, Giuseppe .

VACCINE, 2009, 27 (25-26) :3376-3384

← 1 2 3 →